Genetic Association of Curative and Adverse Reactions to Tyrosine Kinase Inhibitors in Chinese advanced Non-Small Cell Lung Cancer patients
出版年份 2016 全文链接
标题
Genetic Association of Curative and Adverse Reactions to Tyrosine Kinase Inhibitors in Chinese advanced Non-Small Cell Lung Cancer patients
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-03-18
DOI
10.1038/srep23368
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non–Small-Cell Lung Cancer
- (2015) Hiroyuki Kobayashi et al. Clinical Lung Cancer
- Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms
- (2014) Sariah Liu et al. CANCER TREATMENT REVIEWS
- Genetic variants in AKT1 gene were associated with risk and survival of OSCC in Chinese Han Population
- (2014) Yun Wang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Tyrosine Kinase Inhibitors: Their On-Target Toxicities as Potential Indicators of Efficacy
- (2013) Devron R. Shah et al. DRUG SAFETY
- miRBase: annotating high confidence microRNAs using deep sequencing data
- (2013) Ana Kozomara et al. NUCLEIC ACIDS RESEARCH
- Skin Rash could Predict the Response to EGFR Tyrosine Kinase Inhibitor and the Prognosis for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
- (2013) Hong-bing Liu et al. PLoS One
- Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2013) Alberto Bardelli et al. Cancer Discovery
- Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer
- (2012) Tomohiro Suzumura et al. BMC CANCER
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effect of the CYP2C19 genotype on the pharmacokinetics of icotinib in healthy male volunteers
- (2012) Can-Jun Ruan et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Association Study of 27 Annotated Genes for Clozapine Pharmacogenetics
- (2012) Seung-Tae Lee et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: A literature-based meta-analysis of 24 trials
- (2012) Fausto Petrelli et al. LUNG CANCER
- EGFR 3′UTR 774T>C polymorphism contributes to bladder cancer risk
- (2012) Haiyan Chu et al. MUTAGENESIS
- Pharmacogenetics ofEGFRin lung cancer: perspectives and clinical applications
- (2012) Clara Mayo et al. PHARMACOGENOMICS
- AKT1 polymorphisms and survival of early stage non-small cell lung cancer
- (2011) Min Jung Kim et al. JOURNAL OF SURGICAL ONCOLOGY
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
- (2011) Caicun Zhou et al. LANCET ONCOLOGY
- Impact ofABCG2polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients
- (2011) Clara Lemos et al. PHARMACOGENOMICS
- Pharmacogenomic and Pharmacokinetic Determinants of Erlotinib Toxicity
- (2008) Charles M. Rudin et al. JOURNAL OF CLINICAL ONCOLOGY
- Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia
- (2008) Masashi Ikeda et al. PHARMACOGENOMICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now